BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23843100)

  • 1. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
    Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
    Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and function of miRNA-451 in non-small cell lung cancer.
    Wang XC; Tian LL; Jiang XY; Wang YY; Li DG; She Y; Chang JH; Meng AM
    Cancer Lett; 2011 Dec; 311(2):203-9. PubMed ID: 21875770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
    Chen Y; Min L; Ren C; Xu X; Yang J; Sun X; Wang T; Wang F; Sun C; Zhang X
    PLoS One; 2017; 12(2):e0171751. PubMed ID: 28199399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
    Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
    Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
    Salim H; Arvanitis A; de Petris L; Kanter L; Hååg P; Zovko A; Özata DM; Lui WO; Lundholm L; Zhivotovsky B; Lewensohn R; Viktorsson K
    Genes Chromosomes Cancer; 2013 Oct; 52(10):895-911. PubMed ID: 23929716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.
    Li J; Yu T; Cao J; Liu L; Liu Y; Kong HW; Zhu MX; Lin HC; Chu DD; Yao M; Yan MX
    Cell Physiol Biochem; 2015; 37(5):1847-56. PubMed ID: 26584284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T; Ohyashiki JH; Hirano T; Kato H; Ohyashiki K
    Oncol Rep; 2004 Aug; 12(2):389-95. PubMed ID: 15254707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
    Zhang B; Liu T; Wu T; Wang Z; Rao Z; Gao J
    Int J Biol Macromol; 2015 Mar; 74():111-8. PubMed ID: 25498886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.
    Yang X; Zhang Z; Qiu M; Hu J; Fan X; Wang J; Xu L; Yin R
    Cancer Lett; 2013 Dec; 341(2):265-73. PubMed ID: 23962560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
    Chang HC; Cho CY; Hung WC
    Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer.
    Nakagawa T; Endo H; Yokoyama M; Abe J; Tamai K; Tanaka N; Sato I; Takahashi S; Kondo T; Satoh K
    Biochem Biophys Res Commun; 2013 Jun; 436(2):319-24. PubMed ID: 23743197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
    Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
    Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
    Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.